Pherin Pharmaceuticals lead program PH94B nasal spray, a Phase 3 ready product, is being developed for the acute treatment of Social Anxiety Disorder under USFDA guidance.

Pherin Pharmaceuticals

Phone Icon (650) 383-4642


Scientific Advisors

The medical and scientific advisors associated with Pherin Pharmaceuticals are experts in their respective fields. We remain current and on the cusp of scientific advancement with our knowledgeable team of advisors.

Michael B. Liebowitz, MD

Michael B. Liebowitz, MD is Associate Professor of Clinical Psychiatry at Columbia University, NY; Director of the Anxiety Disorders Clinic at the New York State Psychiatric Institute and Managing Director of the Medical Research Network. Dr. Liebowitz is recognized as one of the world's leading researchers in the field of anxiety disorders. He assists us with the clinical development of our anxiety program.

Ellen Freeman, PhD

Ellen Freeman, Ph.D. is Research Professor and Co-Director of the Human Behavior and Reproduction Unit in the Department of Obstetrics and Gynecology at the University of Pennsylvania. Dr. Freeman currently serves on the Health Behavior and Prevention Review Committee, National Institute of Mental Health and also serves as a reviewer for numerous scientific and professional journals. Dr. Freeman is recognized internationally as one of the leading researchers in the field of premenstrual syndrome (PMS). She assists us with our clinical development program on premenstrual syndrome.

Gustavo A. García de la Mora, PhD

Gustavo A. García de la Mora, Ph.D. is Professor of Chemistry at the Faculty of Chemistry of the National Autonomous University of Mexico. He has over 30 years of experience in the synthesis of organic compounds, particularly steroids. He consults for the World Health Organization and several chemical companies. Dr. García de la Mora guides the synthesis of new pherines at pilot and industrial scales.

Rita Hanover, PhD

Rita Hanover, Ph.D. is a Healthcare Analyst with years of experience in clinical trials. Dr. Hanover obtained her Ph.D. at the University of Utah and is currently associated with HealthInsight. She assists with our clinical development program in all aspects related to statistical analysis.

José Vicente Díaz-Sánchez, MD, PhD

José Vicente Díaz-Sánchez, MD, Ph.D. has held the position of coordinator of the pharmacokinetics unit and the infertility unit at the National Institute of Nutrition, Department of Biology and Reproduction, in Mexico City. He has lectured and published extensively in the fields of endocrinology and contraception. The World Health Organization recently honored him for his collaborations on human reproduction. Dr. Díaz-Sánchez studies the effects of pherines on the endocrine system.